Clinical Pharmacology Details


FOSINOPRIL


View Drug Forms

Indications & Dose:

Adult and Child >16 yr 



Hypertension:


PO 10 mg qd; usual dose range, 20-40 mg qd; maximal dose 40 mg qd, though dose response curve usually flat after 40 mg qd


Congestive heart failure


PO 5 (for volume-depleted, moderate to severe renal failure) = 10 mg qd; usual dose range 20-40 mg qd or titrate to systolic blood pressure of 100 mm Hg


Myocardial infarction


PO 5 mg initial dose, repeated in 24 hr, with progressive doubling to a maximum dose of 20 mg qd, if systolic blood pressure remains over 100 mm Hg (fosinopril in acute myocardial infarction study, FAMIS)


Renal failure


PO <7.5 mg qd if CrCi < 10 ml/min 

Contraindications:

Side Effects:

CNS: Anxiety, dizziness, fatigue, headache, insomnia, paresthesia


CVS: Angina, hypotension, palpitations, postural hypotension, syncope (especially with 1st dose)


GI: Abdominal pain, constipation, melena, nausea, vomiting


GU: Decreased libido, impotence, increased BUN, creatinine, UTI


HEME: Agranulocytosis, neutropenia


METAB: Hyperkalemia, hyponatremia


MS: Arthralgia, arthritis, myalgia


RESP: Asthma, bronchitis, cough, dyspnea, sinusitis


SKIN: Angioedema, flushing, rash, sweating


 

Cautions:

Precautions:

History of anaphylaxis, renal insufficiency (<30 ml/min), hypotension (CHF, elderly, volume depletion-diuretics, dialysis, cirrhosis), aortic stenosis, hyperkalemia (potassium supplements, potassium sparing diuretics, renal disease, diabetes), neutropenia (autoimmune diseases, collagen vascular, febrile illness, immunosuppressant drug therapy), proteinuria, renal artery stenosis, surgery/anesthesia (excessive hypotension, correctable with fluids)  


BREAST FEEDING Not recommended; alternative treatment options, with better established safety information during breast-feeding, are available. l


HEPATIC IMPAIRMENT Fosinopril is a prodrug and requires close monitoring in patients with hepatic impairment


 

Interaction:

Drugs 


Allopurinol: Combination may predispose to hypersensitivity reactions


a adrenergic blockers: Exaggerated first dose hypotensive response when added to fosinopril


10 Aspirin: May reduce hemodynamic effects of fosinopril; less likely at doses under 236 mg; less likely with nonacetylated salicylates


Azathioprine: Increased myelosuppression


Cyclosporine: Combination may cause renal insufficiency


Insulin: Fosinopril may enhance insulin sensitivity


Iron: Fosinopril may increase chance of systemic reaction to IV iron


Lithium: Reduced lithium clearance


Loop diuretics: Initiation of fosinopril may cause hypotension and renal insufficiency in patients taking loop diuretics


NSAIDs: May reduce hemodynamic effects of fosinopril


Potassium-sparing diuretics: Increased risk of hyperkalemia


Trimethoprim: Additive risk of hyperkalemia, especially in patient predisposed to renal insufficiency


 


 

Warnings:

Adverse Effects:

Lactations:

Special Precautions:

Counselling:

Side Effects Or Adverse Reactions:

Patient And Carer Advice: